| A model to predict survival in patients with end–stage liver disease PS Kamath, RH Wiesner, M Malinchoc, W Kremers, TM Therneau, ... Hepatology 33 (2), 464-470, 2001 | 6372 | 2001 |
| Model for end-stage liver disease (MELD) and allocation of donor livers R Wiesner, E Edwards, R Freeman, A Harper, R Kim, P Kamath, ... Gastroenterology 124 (1), 91-96, 2003 | 3087 | 2003 |
| The model for end-stage liver disease (MELD) PS Kamath, RW Kim Hepatology 45 (3), 797-805, 2007 | 1886 | 2007 |
| Hyponatremia and mortality among patients on the liver-transplant waiting list WR Kim, SW Biggins, WK Kremers, RH Wiesner, PS Kamath, JT Benson, ... New England Journal of Medicine 359 (10), 1018-1026, 2008 | 1592 | 2008 |
| Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites P Angeli, P Ginès, F Wong, M Bernardi, TD Boyer, A Gerbes, R Moreau, ... Gut 64 (4), 531-537, 2015 | 1327 | 2015 |
| Increased prevalence and mortality in undiagnosed celiac disease A Rubio–Tapia, RA Kyle, EL Kaplan, DR Johnson, W Page, F Erdtmann, ... Gastroenterology 137 (1), 88-93, 2009 | 1081 | 2009 |
| MELD and PELD: application of survival models to liver allocation RH Wiesner, SV McDiarmid, PS Kamath, EB Edwards, M Malinchoc, ... Liver transplantation 7 (7), 567-580, 2001 | 1076 | 2001 |
| Evidence-based incorporation of serum sodium concentration into MELD SW Biggins, WR Kim, NA Terrault, S Saab, V Balan, T Schiano, J Benson, ... Gastroenterology 130 (6), 1652-1660, 2006 | 985 | 2006 |
| Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease WR Kim, SL Flamm, AM Di Bisceglie, HC Bodenheimer Hepatology 47 (4), 1363-1370, 2008 | 963 | 2008 |
| Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States D Kim, RW Kim, HJ Kim, TM Therneau Hepatology 57 (4), 1357-1365, 2013 | 845 | 2013 |
| Burden of liver disease in the United States: summary of a workshop WR Kim, RS Brown Jr, NA Terrault, H El‐Serag Hepatology 36 (1), 227-242, 2002 | 806 | 2002 |
| The burden of hepatitis C in the United States RW Kim Hepatology 36, S30-S34, 2002 | 692 | 2002 |
| MELD accurately predicts mortality in patients with alcoholic hepatitis W Dunn, LH Jamil, LS Brown, RH Wiesner, WR Kim, KVN Menon, ... Hepatology 41 (2), 353-358, 2005 | 689 | 2005 |
| Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers SD Murad, WR Kim, DM Harnois, DD Douglas, J Burton, LM Kulik, ... Gastroenterology 143 (1), 88-98. e3, 2012 | 613 | 2012 |
| Risk factors for mortality after surgery in patients with cirrhosis SH Teh, DM Nagorney, SR Stevens, KP Offord, TM Therneau, DJ Plevak, ... Gastroenterology 132 (4), 1261-1269, 2007 | 581 | 2007 |
| Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community K Bambha, WR Kim, J Talwalkar, H Torgerson, JT Benson, TM Therneau, ... Gastroenterology 125 (5), 1364-1369, 2003 | 554 | 2003 |
| Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study … SW Biggins, P Angeli, G Garcia‐Tsao, P Ginès, SC Ling, MK Nadim, ... Hepatology 74 (2), 1014-1048, 2021 | 496 | 2021 |
| OPTN/SRTR 2016 annual data report: liver WR Kim, JR Lake, JM Smith, DP Schladt, MA Skeans, AM Harper, ... American Journal of Transplantation 18, 172-253, 2018 | 471 | 2018 |
| Epidemiology and natural history of primary biliary cirrhosis in a US community WR Kim, KD Lindor, GR Locke III, TM Therneau, HA Homburger, KP Batts, ... Gastroenterology 119 (6), 1631-1636, 2000 | 447 | 2000 |
| A revised natural history model for primary sclerosing cholangitis WR Kim, TM Therneau, RH Wiesner, JJ Poterucha, JT Benson, ... Mayo Clinic Proceedings 75 (7), 688-694, 2000 | 441 | 2000 |
